Marshall Wace
ELV icon

Marshall Wace’s Elevance Health ELV Stock Holding History

Marshall Wace’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-100
Closed -$32.3K – 3088
2025
Q3 		$32.3K Buy
+100
New +$31.1K ﹤0.01% 2757

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Marshall Wace's ELV Position: Q1 2026 in Review

Marshall Wace opened a new position in Elevance Health (ELV) in Q1 2026: 3,800 shares worth $1.11M. The stake represents ﹤0.01% of the portfolio and ranks #2087 among its holdings. This is a return to the name: Marshall Wace previously reported a position in ELV as recently as Q3 2025.

Marshall Wace first reported a position in ELV in Q1 2014 and has held it in 33 quarters since. The position peaked at $251M in Q1 2023. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Marshall Wace held 3,800 shares of Elevance Health worth $1.11M as of Q1 2026.
  • Elevance Health was a new Marshall Wace position in Q1 2026.
  • Elevance Health made up ﹤0.01% of Marshall Wace's portfolio in Q1 2026, its #2087 holding.
  • Marshall Wace first reported a position in Elevance Health in Q1 2014 and has held it in 33 quarters since.
  • Marshall Wace's Elevance Health position peaked at $251M in Q1 2023.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.